Author | Howard "Skip" A. Burris, III, MD | OncLive

Author | Howard "Skip" A. Burris, III, MD

Articles

Dr. Burris on the Incorporation of Biosimilars in Oncology

January 10, 2020

Howard "Skip" A. Burris, III, MD, chief medical officer and president, Clinical Operations, Sarah Cannon Research Institute, 2019 ASCO president-elect, and a 2014 Giant of Cancer Care® in Drug Development, discusses the incorporation of biosimilars in oncology.

x